Thiazide diuretics are widely used for the treatment of hypertension, but the mechanism by which these drugs lower blood pressure in the long term remains unknown. This article reviews current knowledge about the hypotensive actions of thiazides and thiazide-like diuretics and discusses possible mechanisms of action.
Freis EDStudies in hemodynamics and hypertension. Hypertens2001;38:1-5.
2.
Chobanian AV , Bakris GL, Lack HR et al. Joint National Commitee on Prevention of High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertens2003;42:1206-52.
3.
Williams B., Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens2004;18:139-85.
4.
Beyer KH Jr.Special therapeutics: physiology of diuretics. Annu Rev Med1960;11:377-402.
5.
Schaeffer P. , Vigne P., Frelin C., Lazdunski M.Identification and pharmacological properties of binding sites for the atypical thiazide diuretic, indapamide. Eur J Pharmacol1990 ;182: 503-08.
6.
Puscas I., Coltau M., Baican M., Pasca R., Domuta G.The inhibitory effect of diuretics on carbonic anhydrases. Res Commun Mol Pathol Pharmacol1999;105:213-36.
7.
Ellison DH, Velazquez H., Wright FSThiazide-sensitive sodium chloride cotransport in early distal tubule . Am J Physiol1987;253:F546-F554.
8.
Vazquez N., Monroy A., Dorantes E., Munoz-Clares RA, Gamba G.Functional differences between flounder and rat thiazide-sensitive Na-Cl cotransporter . Am J Physiol Renal Physiol2002;282:F599-F607.
9.
Lukeman DS, Fanestil DDInteractions of diuretics with the peripheral-type benzodiazepine receptor in rat kidney. J Pharmacol Exp Ther1987;241:950-5.
10.
Campbell DB , Moore RAThe pharmacology and clinical pharmacology of indapamide. Postgrad Med J1981;57(suppl 2):7-17.
11.
Mironneau J. , Savineau JP, Mironneau C.Compared effects of indapamide, hydrochlorothiazide and chlorthalidone on electrical and mechanical activities in vascular smooth muscle. Eur J Pharmacol1981;75:109-13.
12.
Del RM, Chulia T., Gonzalez Tejerina T.Effects of indapamide on contractile responses and 45Ca2+ movements in various isolated blood vessels. Eur J Pharmacol1993 ;250:1339.
13.
Calder JA, Schachter M., Sever PSVasorelaxant actions of 5-OH-indapamide, a major metabolite of indapamide: comparison with indapamide, hydrochlorothiazide and cicletanine. Eur J Pharmacol1994;256:185-91.
14.
Zempel G., Ditlevsen J., Hoch M. et al. Effects of indapamide on Ca2+ entry into vascular smooth muscle cells. Nephron1997;76:460-5.
de Jong JC, Willems PH, Mooren FJ, van den Heuvel LP, Knoers NV, Bindels RJThe structural unit of the thiazide-sensitive NaCl cotransporter is a homodimer . J Biol Chem2003; 278:24302-07.
17.
Hebert SC, Mount DB, Gamba G.Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. PflugersArch2004;447:580-93.
18.
Greger R.Physiology of renal sodium transport. Am J Med Sci2000;319:51-62.
19.
Mastroianni N., De FM, Zollo M. et al. Molecular cloning, expression pattern, and chromosomal localization of the human Na-Cl thiazide-sensitive cotransporter (SLC12A3). Genomics1996; 35:486-93.
20.
Chang H.,Tashiro K., Hirai M., Ikeda K., Kurokawa K., FujitaT.Identification of a cDNA encoding a thiazide-sensitive sodium-chloride cotransporter from the human and its mRNA expression in various tissues. Biochem Biophys Res Commun1996; 223:324-8.
21.
Abuladze N. , Yanagawa N., Lee I. et al. Peripheral blood mononuclear cells express mutated NCCT mRNA in Gitelman's syndrome: evidence for abnormal thiazide-sensitive NaCl cotransport. J Am Soc Nephrol1998;9:819-26.
22.
Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PAExpression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol1997;272: C109-C116.
23.
Tran JM, Farrell MA, Fanestil DDEffect of ions on binding of the thiazide-type diuretic metolazone to kidney membrane. Am J Physiol1990;258:F908-F915.
24.
Monroy A., Plata C., Hebert SC, Gamba G.Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a new model for ions and diuretics interaction. Am J Physiol Renal Physiol2000;279:F161-F169.
25.
Moreno E., Tovar-Palacio C., de los HP et al. A single nucleotide polymorphism alters the activity of the renal Na+:Cl- cotransporter and reveals a role for transmembrane segment 4 in chloride and thiazide affinity. J Biol Chem2004; 279:16553-60.
26.
Goodman LS, Gilman A.The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, editors. 1-9-2001. Mc Graw-Hill Education. RefType: Serial (Book, Monograph)
27.
Uwai Y., Saito H., Hashimoto Y., Inui KIInteraction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther2000;295:261-5.
28.
Hasannejad H. , Takeda M., Taki K. et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther2004;308:1021-9.
29.
Ogihara T., Katsuya T., Ishikawa K. et al. Hypertension in a patient with Gitelman's syndrome. J Hum Hypertens2004;18: 677-9.
30.
Kunchaparty S., Palcso M., Berkman J. et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome . Am J Physiol1999; 277:F643-F649.
31.
Sabath E., Meade P., Berkman J. et al. Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease. Am J Physiol Renal Physiol2004; 287:F195-F203.
32.
Schultheis PJ, Lorenz JN, Meneton P. et al. Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule. J Biol Chem1998 ;273:29150-5.
33.
Mayan H.,Vered I., Mouallem M.,Tzadok-Witkon M., Pauzner R., Farfel Z.Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab2002;87:3248-
34.
34. Wilson FH, Disse-Nicodeme S., Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science2001;293:1107-12.
35.
Yang CL, Angell J., Mitchell R., Ellison DHWNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest2003; 111:1039-45.
36.
Wilson FH, Kahle KT, Sabath E. et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA2003;100:680-4.
37.
Freis ED,Wanko A., Wilson IM, Parrish AEChlorothiazide in hypertensive and normotensive patients. Ann N Y Acad Sci1958;71:450-5.
38.
Dustan HP, Cumming GR, Corcoran AC, Page IHA mechanism of chlorothiazide-enhanced effectiveness of antihypertensive ganglioplegic drugs. Circulation1959;19:360-5.
39.
Dollery CT, Harington M., Kaufmann G.The mode of action of chlorothiazide in hypertension: with special reference to potentiation of ganglion-blocking agents. Lancet1959;1:1215-18.
40.
Wilson IM, Freis EDRelationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation1959;20:1028-36.
41.
Conway J., Lauwers P.Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide . Circulation1960;21:21-7.
42.
Frohlich ED , Schnaper HW, Wilson IM, Freis EDHemodynamic alterations in hypertensive patients due to chlorothiazide. N Engl J Med1960;262:1261-3.
43.
Lake CR, Ziegler MG, Coleman MD, Kopin IJHydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients . Clin Pharmacol Ther1979;26:428-32.
44.
van , BPMan in 't Veld AJ, Schalekamp MAHemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther1980 ;27:328-36.
45.
Anderson GH Jr, Dalakos TG, Elias A., Tomycz N., Streeten DHDiuretic therapy and response of essential hypertension to saralasin. Ann Intern Med1977;87:183-7.
46.
Flack JM, Cushman WCEvidence for the efficacy of low-dose diuretic monotherapy. Am J Med1996;101:53S-60S.
47.
Beermann B. , Groschinsky-Grind M.Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Eur J Clin Pharmacol1978; 13:195-201.
48.
Araoye MA, Chang MY, Khatri IM, Freis EDFurosemide compared with hydrochlorothiazide. Long-term treatment of hypertension .JAMA1978;240:1863-6.
49.
Materson BJ , Reda DJ, Cushman WC et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group onAntihypertensiveAgents . N Engl J Med1993;328:914-21.
50.
Freis ED, Reda DJ, Materson BJVolume (weight) loss and blood pressure response following thiazide diuretics . Hypertens1988;12:244-50.
51.
Ripley E., King K., Sica DARacial differences in response to acute dosing with hydrochlorothiazide . Am J Hypertens2000;13:157-64.
52.
Winer BMThe antihypertensive actions of benzothiadiazines. Circulation1961;23:211-18.
53.
Gifford RW, Jr., Mattox VR, Orvis AL, Sones DA, Rosevear JWEffect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation1961;24:1197-205.
54.
de Carvalho JG, Dunn FG, Lohmoller G., Frohlich EDHemodynamic correlates of prolonged thiazide therapy: comparison of responders and nonresponders . Clin Pharmacol Ther1977;22:875-80.
55.
Shah S., Khatri I., Freis EDMechanism of antihypertensive effect of thiazide diuretics. Am Heart J1978;95:611-18.
56.
Lund-Johansen P.Hemodynamic changes in long-term diuretic therapy of essential hypertension.A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide. Acta Med Scand1970 ;187:509-18.
57.
Tarazi RC, Dustan HP, Frohlich EDLong-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circ1970;41:709-17.
58.
Beermann B. , Groschinsky-Grind M., Rosen A.Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther1976;19:531-7.
59.
Beermann B. , Hellstrom K., Lindstrom B., Rosen A.Bindingsite interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells . Clin Pharmacol Ther1975;17: 424-32.
60.
Shah VP, Walker MA, Hunt JP, Schuirmann D., Prasad VK, Cabana BEThiazides XI: partitioning of chlorothiazide in red blood cells after oral administration. Biopharm Drug Dispos blood cells after oral administration . Biopharm Drug Dispos1984;5:55-62.
61.
Caruso FS, Szabadi RR, Vukovich RAPharmacokinetics and clinical pharmacology of indapamide. Am Heart J1983; 106:212-20.
62.
Cohen AI, Hartman AD, Hinsvark ON, Kraus PF, Zazulak W.Physiological disposition of a new diuretic, 14 C-metolazone, in dogs . J Pharm Sci1973;62:931-6.
63.
Tobian L.Why do thiazide diuretics lower blood pressure in essential hypertension?Annu Rev Pharmacol1967;7:399-408.
64.
Roos JC, Boer P., Koomans HA, Geyskes GG, Dorhout Mees EJHaemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension. Eur J Clin Pharmacol1981;19:107-12.
65.
Morsing P., Velazquez H., Wright FS, Ellison DHAdaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion. Am JPhysiol1991;261:F137-F143.
66.
Loffing J., Loffing-Cueni D., Hegyi I. et al.Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int1996;50:1180-90.
67.
Bennett WM, McDonald WJ, Kuehnel E., Hartnett MN, Porter GADo diuretics have antihypertensive properties independent of natriuresis?Clin Pharmacol Ther1977;22:499-504.
68.
Jones B., Nanra RSDouble-blind trial of antihypertensive effect of chlorothiazide in severe renal failure. Lancet1979; 2:1258-60.
69.
Beavers WR, Blackmore WPEffect of chlorothiazide on vascular reactivity. Proc Soc Exp Biol Med1958;98:133-5.
70.
Silah JG, Jones RE, Bashour FA, Kaplan NMThe effect of acute administration of chlorothiazide upon the pressor responsiveness to angiotensin and norepinephrine. Am Heart J1965;69:301-05.
71.
Aleksandrow D., Wysznacka W., Gajewski J.Influence of chlorothiazide upon arterial responsiveness to norepinephrine in hypertensive subjects. N Engl JMed1959;261:1052-5.
72.
Freis ED, Wanko A., Schnaper HW, Frohlich EDMechanism of the altered blood pressure responsiveness produced by chlorothiazide . J Clin Invest1960;39:1277-81.
73.
Jandhyala BS , Cavero I., Buckley JPEffects of prolonged hydrochlorothiazide administration on neurogenic tone in the hind limb vasculature . Eur J Pharmacol1972;17:357-64.
74.
ZsoterTT,Hart F. , Radde IC, Endrenyi L.Effect of chlorthalidone on blood vessels . J Pharmacol Exp Ther1972 ;180:723-31.
75.
Feisal KA, Eckstein JW, Horsley AW, Keasling HHEffects of chlorothiazide on forearm vascular responses to norepinephrine . J Appl Physiol1961;16:549-52.
76.
Preziosi P. , De Schaepdryver AF, Marmo E., Miele E.On the mechanism of the anti-hypertensive effect of hydrochlorothiazide . Arch Int Pharmacodyn Ther1961;131:209-29.
77.
Gillenwater JY , Scott JB, Frohlich EDEffect of chlorothiazide on response of renal vascular bed to vasoactive substances. Circ Res1962;11:283-6.
78.
Pickkers P. , Hughes AD, Russel FG,Thien T.,Smits P.Thiazideinduced vasodilation in humans is mediated by potassium channel activation . Hypertension1998;32:1071-6.
79.
Pickkers P. , Russel FG, Hughes AD, Thien T., Smits P.Hydrochlorothiazide exerts no direct vasoactivity in the human forearm . J Hypertens1995;13:1833-6.
80.
ZsoterTT,Hart F. , Radde ICMechanism of antihypertensive action of prolonged administration of hydrochlorothiazide in rabbit and dog . Circ Res1970;27:717-25.
81.
Abrahams Z. ,Tan LL, Pang MY, Abrahams B.,Tan MM, Wright JMDemonstration of an in vitro direct vascular relaxant effect of diuretics in the presence of plasma. J Hypertens1996;14: 381-8.
82.
Abrahams Z. , Pang MY, Lam EK, Wright JMWhat is the plasma cofactor required by diuretics for direct vascular relaxant effect in vitro?J Hypertens1998;16:801-09.
83.
Colas B., Slama M., Masson H. et al. Direct vascular actions of methyclothiazide and indapamide in aorta of spontaneously hypertensive rats. Fundam Clin Pharmacol2000;14:363-8.
84.
Colas B., Slama M., Collin T., Safar M., Andrejak M.Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta. Eur J Pharmacol2000;408:63-7.
85.
Calder JA, Schachter M., Sever PSInteraction between cicletanine and the eicosanoid system in human subcutaneous resistance arteries. J Pharm Pharmacol1992 ;44:574-8.
86.
Moura AM,Worcel M.Mode of action of cyclothiazide and triamterene. Ex vivo effect on 22Na and 86Rb efflux from arterial smooth muscle.EurJPharmacol1982;86:129-33.
87.
Calder JA, Schachter M., Sever PSIon channel involvement in the acute vascular effects of thiazide diuretics and related compounds. J Pharmacol Exp Ther1993;265:1175-80.
88.
Calder JA, Schachter M., Sever PSPotassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries. J Cardiovasc Pharmacol1994;24: 158-64.
89.
Pickkers P. , Hughes ADRelaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea-pig isolated mesenteric arteries. Br J Pharmacol1995;114:703-07.
90.
Pickkers P. , Garcha RS, Schachter M., Smits P., Hughes ADInhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide . Hypertension1999;33: 1043-8.
91.
Vorstrup S. , Henriksen L., Paulson OBEffect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest1984;74:1634-9.
92.
Pickkers P. , Hughes AD, Russel FG, Thien T., Smits P.In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature . Br J Pharmacol2001;132: 443-50.
93.
Tricarico D. , Barbieri M., Mele A., Carbonara G., Camerino DCCarbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats, FASEB J2004;18:760-1.
